Stoke Therapeutics (STOK) Cash from Financing Activities (2018 - 2026)
Stoke Therapeutics' quarterly Cash from Financing Activities came in at $84.3 million in Q1 2026, up 6037.34% year-on-year from $1.4 million in Q1 2025, and down 8.68% quarter-over-quarter from $92.3 million in Q4 2025.
Stoke Therapeutics has reported Cash from Financing Activities for 9 years, with the latest figure at $84.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 6037.34% year-over-year to $84.3 million; the trailing twelve-month figure through Mar 2026 stood at $180.3 million (up 37.93% YoY), and the FY2025 full-year result was $97.4 million, down 25.71% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $84.3 million, down from $92.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $120.6 million in Q2 2024, with the low at $43000.0 in Q4 2022.
- Average Cash from Financing Activities over 5 years is $24.2 million, with a median of $3.1 million recorded in 2025.
- Year-over-year, Cash from Financing Activities soared 251254.17% in 2024 and plunged 99.54% in 2025.
- Tracing STOK's Cash from Financing Activities over 5 years: stood at $43000.0 in 2022, then jumped by 16976.74% to $7.3 million in 2023, then slumped by 92.26% to $568000.0 in 2024, then jumped by 16157.22% to $92.3 million in 2025, then retreated by 8.68% to $84.3 million in 2026.
- The last three Cash from Financing Activities figures came in at $84.3 million (Q1 2026), $92.3 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | 84.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.33 Mn |
| Mar 31, 2026 | 84.33 Mn |
| Dec 31, 2025 | 92.34 Mn |
| Dec 31, 2025 | 92.34 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.12 Mn |
| Jun 30, 2025 | 554,000.00 |
| Jun 30, 2025 | 554,000.00 |
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 568,000.00 |
| Dec 31, 2024 | 568,000.00 |
| Sep 30, 2024 | 8.16 Mn |
| Sep 30, 2024 | 8.16 Mn |
| Jun 30, 2024 | 120.65 Mn |
| Jun 30, 2024 | 120.65 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Sep 30, 2023 | 562,000.00 |
| Sep 30, 2023 | 562,000.00 |
| Jun 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 48,000.00 |
| Mar 31, 2023 | 45.05 Mn |
| Mar 31, 2023 | 45.05 Mn |
| Dec 31, 2022 | 43,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Sep 30, 2022 | 434,000.00 |
| Jun 30, 2022 | 3.43 Mn |
| Jun 30, 2022 | 3.43 Mn |
| Mar 31, 2022 | 42.51 Mn |
| Mar 31, 2022 | 42.51 Mn |
| Dec 31, 2021 | 171,000.00 |
| Dec 31, 2021 | 171,000.00 |
| Sep 30, 2021 | 408,000.00 |
| Sep 30, 2021 | 408,000.00 |
| Jun 30, 2021 | 159,000.00 |
| Jun 30, 2021 | 159,000.00 |
| Mar 31, 2021 | 546,000.00 |
| Mar 31, 2021 | 546,000.00 |
| Dec 31, 2020 | 106.87 Mn |
| Dec 31, 2020 | 106.87 Mn |
| Sep 30, 2020 | 673,000.00 |
| Sep 30, 2020 | 673,000.00 |
| Jun 30, 2020 | 369,000.00 |
| Jun 30, 2020 | 369,000.00 |
| Mar 31, 2020 | 198,000.00 |
| Mar 31, 2020 | 198,000.00 |
| Dec 31, 2019 | 192,000.00 |
| Dec 31, 2019 | 192,000.00 |
| Sep 30, 2019 | -1.00 Mn |
| Sep 30, 2019 | -1.00 Mn |
| Jun 30, 2019 | 150.64 Mn |
| Jun 30, 2019 | 150.64 Mn |
| Mar 31, 2019 | -68,000.00 |
| Mar 31, 2019 | -68,000.00 |
| Dec 31, 2018 | 89.78 Mn |
| Dec 31, 2018 | 89.78 Mn |
| Sep 30, 2018 | 13.38 Mn |
| Sep 30, 2018 | 13.38 Mn |